The elevated expression of TRIM29 in colorectal cancer, gastric cancer, and lung cancer leads to an increase in the invasive phenotype of malignant tumors, while in breast cancer and Merkel cell carcinoma plays an inhibitory role [42]. Here, TRIM29 is linked to breast cancer.